875 related articles for article (PubMed ID: 16144208)
1. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis: from the bench to clinical targets.
Pinzani M; Rombouts K
Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis.
Liu X; Hu H; Yin JQ
Liver Int; 2006 Feb; 26(1):8-22. PubMed ID: 16420505
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutical targets for revert liver fibrosis].
García B L; Gálvez G J; Armendáriz B J
Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Friedman SL
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
[TBL] [Abstract][Full Text] [Related]
6. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
[TBL] [Abstract][Full Text] [Related]
7. Gene regulation in hepatic stellate cell.
Lang A; Brenner DA
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):173-9. PubMed ID: 10363203
[TBL] [Abstract][Full Text] [Related]
8. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cells as a target for the treatment of liver fibrosis.
Bataller R; Brenner DA
Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
[TBL] [Abstract][Full Text] [Related]
10. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells and the reversal of fibrosis.
Kisseleva T; Brenner DA
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
[TBL] [Abstract][Full Text] [Related]
13. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
14. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
Svegliati-Baroni G; De Minicis S; Marzioni M
Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic fibrogenesis].
Loréal O; Clément B; Deugnier Y
Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
[TBL] [Abstract][Full Text] [Related]
16. Chronic liver injury, TGF-beta, and cancer.
Bissell DM
Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
[TBL] [Abstract][Full Text] [Related]
17. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
18. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
Kuriyama S; Yokoyama F; Inoue H; Takano J; Ogawa M; Kita Y; Yoshiji H; Deguchi A; Kimura Y; Himoto T; Yoneyama H; Kurokohchi K; Masaki T; Uchida N; Watanabe S
Int J Mol Med; 2007 Feb; 19(2):317-24. PubMed ID: 17203207
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
20. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
Wasmuth HE; Lammert F; Matern S
Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
